News

Analyzing Autoliv's Earnings Outlook for Investors

Analyzing Autoliv's Earnings Outlook for Investors

Anticipating Autoliv's Earnings Report

Autoliv (NYSE: ALV) is gearing up to announce its quarterly earnings soon. Investors are keenly awaiting this report as it provides critical insights into the company’s financial health and future prospects.

Expectations for Earnings

Market analysts are predicting that Autoliv will post an earnings per share (EPS) of $2.05. This estimate serves as a benchmark that determines investor sentiment leading up to the announcement.

Hopes for Positive Forecasts

Supporters of Autoliv are optimistic about the possibility of the company exceeding earnings estimates. They also expect a positive guidance update, which could indicate growth in the upcoming quarter.

Performance History

In the preceding quarter, Autoliv surpassed earnings expectations by $0.21, although this resulted in a slight share price decline of 0.0% the following day. Historical performance plays a significant role in shaping investor expectations and market reactions.

Previous Earnings Metrics

Analyzing the company's earnings trajectory reveals significant trends:

  • Quarter: Q2 2025 | EPS Estimate: $2.00 | EPS Actual: $2.21 | Price Change: -4.00%
  • Quarter: Q1 2025 | EPS Estimate: $1.67 | EPS Actual: $2.15 | Price Change: -1.00%
  • Quarter: Q4 2024 | EPS Estimate: $2.83 | EPS Actual: $3.05 | Price Change: -5.00%
  • Quarter: Q3 2024 | EPS Estimate: $1.95 | EPS Actual: $1.84 | Price Change: 6.00%

Current Share Price Overview

As of the latest update, Autoliv shares are trading at $120.9. The past 52 weeks have shown a robust increase of 21.07% in share value. Such growth inspires confidence among current shareholders as they look forward to the upcoming earnings report.

Analysts' Perspectives

Engaging with the market’s insights helps investors navigate their strategies effectively. Autoliv has received a range of 7 ratings from analysts, collectively indicating a neutral sentiment. The average price target for the next year stands at $132.71, suggesting an encouraging potential uptrend of 9.77% from the current price.

Comparative Analysis with Competitors

Looking at the industry landscape, it's essential to juxtapose Autoliv's performance with its competitors:

  • BorgWarner has an average price target of $48.0 with an Outperform rating, indicating a significant potential downside of 60.3%.
  • Modine Manufacturing, rated with an Outperform trajectory, has a price target of $170.0 and an upside potential of 40.61%.
  • Mobileye Global's Neutral rating comes with a price target of $19.11, reflecting an 84.19% downside potential.

Peer Performance Metrics

Analyzing key financial metrics sheds light on how Autoliv compares within its market:

CompanyConsensusRevenue GrowthGross ProfitReturn on Equity
AutolivNeutral4.18%$501M6.93%
BorgWarnerOutperform0.97%$640M3.85%
Modine ManufacturingOutperform3.22%$165.40M5.33%
Mobileye GlobalNeutral15.26%$252M-0.56%

Critical Insights from the Metrics

From the metrics provided, Autoliv's consensus rating lands in the middle of the pack within its competitors. Although it is lagging behind in terms of revenue growth and gross profit, it shines in return on equity, showcasing effective capital management.

Diving Deeper into Autoliv's Core Operations

Autoliv Inc distinguishes itself as a leader in passive safety systems for the automotive industry, offering a wide range of products from seat belts to airbag systems. Its diverse customer base includes major auto manufacturers like Renault-Nissan-Mitsubishi, Stellantis, and Volkswagen, indicating a strong market share across various regions. Geography-wise, the Americas accounted for 34% of its 2023 revenue, with Europe, China, and the rest of the world contributing significant portions as well.

Analyzing Financial Health

Strong financial metrics indicate Autoliv's solid positioning in the market:

  • Market Capitalization: The company boasts a market cap that surpasses industry averages, revealing a significant presence.
  • Revenue Growth: A recent 4.18% growth rate reflects a positive trend in the top line, although still shy of peer averages.
  • Net Margin: Autoliv's net margin of 6.15% showcases efficient cost control.
  • Return on Equity: At 6.93%, this performance metric highlights strong equity management.
  • Debt Management: The high debt-to-equity ratio of 0.9 suggests reliance on debt, which could be a risk factor.

Frequently Asked Questions

What date will Autoliv release its earnings report?

Autoliv is set to release its earnings report on a Friday in October 2025, with exact details to be confirmed.

What is Autoliv's expected earnings per share?

The expected earnings per share (EPS) for Autoliv is projected to be $2.05.

How has Autoliv performed in previous quarters?

Autoliv has shown fluctuating performance, with some quarters exceeding estimates, yet experiencing a declining share price in the immediate aftermath.

What are analysts saying about Autoliv's stock?

Analysts maintain a neutral stance on Autoliv, with an average price target indicating a potential upside of nearly 10%.

How does Autoliv compare to its competitors?

In comparison to its rivals, Autoliv ranks middle in consensus rating but excels in return on equity metrics.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors of Sage Therapeutics Have Chance to Join Lawsuit

Updated Category News Views 88

Introduction to the Class Action Lawsuit Attention, investors! There's an important opportunity arising for shareholder litigation against Sage Therapeutics, Inc. The legal firm Bronstein, Gewirtz & Grossman, LLC is officially notifying individuals who have invested in Sage Therapeutics about a class action lawsuit that has now been filed. If you have faced substantial...

Continue Reading
FARO Technologies Revolutionizes 3D Metrology with Leap ST

Updated Category News Views 105

FARO Technologies Enhances 3D Metrology with Leap ST FARO Technologies, Inc. (NASDAQ: FARO) is pushing the boundaries of handheld scanning technology with the introduction of the Leap ST. This launch marks a significant expansion of FARO's product portfolio, positioning the company among the few firms offering a comprehensive range of portable 3D metrology solutions. Leap...

Continue Reading
Strong Financial Performance and Growth Strategies at TORM PLC

Updated Category News Views 181

TORM PLC Reports Robust Q3 2025 Financial Results TORM PLC has demonstrated remarkable resilience and adaptability, reporting its strongest quarterly results in 2025. This achievement underscores the effectiveness of TORM's integrated operating model, as highlighted by the CEO. The company continues to prioritize creating long-term value for its shareholders while...

Continue Reading
Manhattan Associates Faces Legal Challenges Amid Shareholder Losses

Updated Category News Views 304

Manhattan Associates Faces Legal Challenges Following Shareholder Loss In recent developments, Manhattan Associates, Inc. (NASDAQ: MANH) is under scrutiny as a class action lawsuit has been filed against the company. This action comes after an alarming drop in shareholder value, amounting to over $4 billion. The lawsuit is pivotal as it involves allegations of misleading...

Continue Reading
BioLife Solutions Announces Upcoming Financial Results

Updated Category News Views 91

BioLife Solutions to Share Key Financial Insights BioLife Solutions, Inc. (NASDAQ: BLFS), a pioneering developer and supplier of bioproduction products and services specializing in cell and gene therapies, is gearing up for a significant event. The company plans to release its financial results for the third quarter of 2024 after market hours on November 12, 2024. This is...

Continue Reading